DARA Biosciences Inc (DARA)

0.88
Prev Close 0.94
Day Low/High 0.88 / 0.95
52 Wk Low/High 0.67 / 1.05
Avg Volume 85.60K
Exchange
Shares Outstanding 19.76M
Market Cap 17.38M
EPS -0.63
Div & Yield N.A. (N.A)

Latest News

3 Biotech Stocks Under $10 to Trade for Breakouts

3 Biotech Stocks Under $10 to Trade for Breakouts

These under-$10 biotech stocks are within range of triggering breakout trades.

5 Stocks Under $10 Set to Soar Higher

5 Stocks Under $10 Set to Soar Higher

These under-$10 stocks look ready to break out and trade higher from current levels.

Why DARA BioSciences (DARA) Stock is Surging Today

Why DARA BioSciences (DARA) Stock is Surging Today

DARA BioSciences (DARA) surged Monday after the company announced the FDA had granted Orphan Drug Designation to the company's experimental compound KRN5500 for the treatment of multiple myeloma.

Gelclair® Is An FDA-approved Bioadherent Oral Rinse Gel For Treating The Pain That Accompanies Oral Mucositis (OM). (Photo: Business Wire)

Gelclair® Is An FDA-approved Bioadherent Oral Rinse Gel For Treating The Pain That Accompanies Oral Mucositis (OM). (Photo: Business Wire)

DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to ...

Why DARA Biosciences (DARA) Stock Is Plunging Today

Why DARA Biosciences (DARA) Stock Is Plunging Today

DARA Biosciences (DARA) plunged Friday after the company priced its offering of common stock at $12.5 million.

DARA Biosciences (DARA) Stock Plunges After Wednesday Surge

DARA Biosciences (DARA) Stock Plunges After Wednesday Surge

DARA Biosciences (DARA) plunged Thursday after the stock's sudden surge on Wednesday.

Dara Biosciences (DARA) Stock Explodes Today (Update)

Dara Biosciences (DARA) Stock Explodes Today (Update)

Dara Biosciences (DARA) soared Wednesday despite a lack of any significant news about the company.

DARA BioSciences Presents Results Of Breast Cancer CAPTURE Registry At NCCN® 19th Annual Conference: Advancing The Standard Of Cancer Care™

DARA BioSciences Presents Results Of Breast Cancer CAPTURE Registry At NCCN® 19th Annual Conference: Advancing The Standard Of Cancer Care™

DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to ...

Breast Cancer Survivor From Wrentham, Mass. And Norton, Mass. Business Owner Appears On The Balancing Act Airing On Lifetime Television To Discuss Breast Cancer Treatment And Tamoxifen Citrate, Soltamox. (Photo: Business Wire)

Breast Cancer Survivor From Wrentham, Mass. And Norton, Mass. Business Owner Appears On The Balancing Act Airing On Lifetime Television To Discuss Breast Cancer Treatment And Tamoxifen Citrate, Soltamox. (Photo: Business Wire)

Julie Megee, a Wrentham resident and breast cancer survivor, will appear on The Balancing Act ® airing on Lifetime Television in October, National Breast Cancer Awareness Month.

Nancy Peacock, MD, And Breast Cancer Survivor, Julie Megee From Wrentham, Mass., Join The Balancing Act(R) Host Danielle Knox In Studio And Discuss Important Oncology Supportive Care Issues (Photo: Business Wire)

Nancy Peacock, MD, And Breast Cancer Survivor, Julie Megee From Wrentham, Mass., Join The Balancing Act(R) Host Danielle Knox In Studio And Discuss Important Oncology Supportive Care Issues (Photo: Business Wire)

DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to ...

DARA BioSciences Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule

DARA BioSciences Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today that on February 12, 2013, NASDAQ notified the Company that it has...

DARA BioSciences To Present At 15th Annual BIO CEO & Investor Conference

DARA BioSciences To Present At 15th Annual BIO CEO & Investor Conference

DARA BioSciences, Inc. (NASDAQ: DARA) (the "Company" or "DARA"), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today the Company will be presenting at the...

5 Stocks Under $10 Poised to Pop

5 Stocks Under $10 Poised to Pop

These under-$10 stocks look ready to trade higher from current levels.

DARA BioSciences To Present At The 6th Annual OneMedForum Conference

DARA BioSciences To Present At The 6th Annual OneMedForum Conference

DARA BioSciences, Inc. (Nasdaq: DARA) (the "Company" or "DARA"), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today the Company will be presenting at the...

DARA BioSciences To Raise $2.8 Million Pursuant To Securities Purchase Agreement

DARA BioSciences To Raise $2.8 Million Pursuant To Securities Purchase Agreement

DARA BioSciences, Inc. (Nasdaq:DARA) (the "Company" or "DARA") announced that it entered into a definitive securities purchase agreement with certain investors providing for the issuance of $2,800,000 of shares of ...

DARA BioSciences Announces Submission Of KRN5500 To FDA For Orphan Designation

DARA BioSciences Announces Submission Of KRN5500 To FDA For Orphan Designation

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it has submitted an Orphan Drug Application to the U.

Dara Biosciences Reports Financial Results For The Third Quarter 2012

Dara Biosciences Reports Financial Results For The Third Quarter 2012

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, and owner of exclusive U.

DARA BioSciences Will Present At NYSSA Investing In Life Sciences Conference, November 29

DARA BioSciences Will Present At NYSSA Investing In Life Sciences Conference, November 29

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it will present at the New York Society of Security Analysts' 16th ...

DARA BioSciences Will Present At Singular Research Conference November 1

DARA BioSciences Will Present At Singular Research Conference November 1

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it will present at the Singular Research seventh annual “Best...

Soltamox, Liquid Version Of Tamoxifen Citrate (Photo: Business Wire)

Soltamox, Liquid Version Of Tamoxifen Citrate (Photo: Business Wire)

Breast Cancer Awareness Month raises visibility and research dollars to address a disease that in the United States claims nearly 40,000 lives annually and affects approximately 240,000 people who each year are newly...

Soltamox, Liquid Version Of Tamoxifen Citrate (Photo: Business Wire)

Soltamox, Liquid Version Of Tamoxifen Citrate (Photo: Business Wire)

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it has launched Soltamox® (tamoxifen citrate) oral...

DARA BioSciences Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule

DARA BioSciences Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology support products (the “Company”), announced today that on October 1, 2012, NASDAQ notified the ...

5 Stocks Under $10 Set to Soar Higher

5 Stocks Under $10 Set to Soar Higher

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

DARA BioSciences Establishes Vertically Integrated Commercial Platform For Specialty Oncology Care And Support Products

DARA BioSciences Establishes Vertically Integrated Commercial Platform For Specialty Oncology Care And Support Products

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology support products, announced today it has a completed a series of agreements with a number of specialty ...

3 Stocks Under $5 Moving Higher

3 Stocks Under $5 Moving Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Helsinn Grants To DARA Exclusive U.S. Commercial Rights To Gelclair®, An FDA-Cleared Oral Gel For The Treatment Of Oral Mucositis

Helsinn Grants To DARA Exclusive U.S. Commercial Rights To Gelclair®, An FDA-Cleared Oral Gel For The Treatment Of Oral Mucositis

The Helsinn Group of Switzerland announced today that it has entered into an exclusive agreement with DARA BioSciences, Inc.

5 Stocks Under $10 Set to Soar Higher

5 Stocks Under $10 Set to Soar Higher

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

DARA BioSciences Names Timothy Heady, Former CEO Of UnitedHealthcare Pharmacy, To Its Board

DARA BioSciences Names Timothy Heady, Former CEO Of UnitedHealthcare Pharmacy, To Its Board

DARA BioSciences, Inc. ( NASDAQ: DARA), a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products, announced today the appointment ...